Maintenance treatment with a mood stabilizer during pregnancy can significantly reduce the risk of relapse in women with bipolar disorder; however, many of the mood stabilizers commonly used in this setting, including lithium and [...]
The following post was first published in OB/GYN News. Please see our OB/GYN News archives here. Publish date: March 3, 2017 Over the last decade, appreciation of the prevalence of perinatal depression – depression during pregnancy and/or [...]
January was Birth Defects Prevention Month, and MotherToBaby launched a free app designed to provide evidence-based information to pregnant and breastfeeding women. There is Information on a broad range of medications, some herbal remedies, [...]
Several studies suggest that postpartum anxiety is relatively common among postpartum women and may even be more common than depression. Emerging evidence also suggests that a large number of postpartum women who do not [...]
It was back in 2005 when we first reported on studies which demonstrated an increased risk of “poor neonatal adaptation” in infants with prenatal exposure to selective serotonin reuptake inhibitor (SSRI) antidepressants in late pregnancy. [...]
When a woman comes in for a consultation regarding the use of medications during pregnancy, we spend most of our time reviewing the potential risks of exposure to medications during pregnancy. However, we must also [...]
In the world of family planning the question “Which contraceptive method is best for me?” is a common one. The World Health Organization (WHO) has tried to address this through a document called Medical Eligibility [...]
A few days ago, an article was published in the journal Pediatrics on neonatal morbidity observed in children exposed to antidepressants. Although this article is likely to find its way into the headlines, it is [...]
Women with bipolar disorder are at a higher risk for relapse during pregnancy and that the risk is even higher during the postpartum period. In addition, women with bipolar disorder are more vulnerable to postpartum [...]
Several studies have observed that fetal exposure to the antiepileptic drug (AED), valproic acid (Depakote), may significantly increase the risk of having a child with an autism spectrum disorder. In contrast, exposures to other AEDs, [...]
